In this study, to obtain in vivo preclinical evidence on the potential use of REL-1017 for ALS treatment, we tested REL-1017 efficacy in the G93A SOD1 mouse by evaluating its effects on survival and motor phenotype, as well as on the expression of genes involved in neuroplasticity. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.